LP
AMGN icon

Longview Partners’s Amgen AMGN Stock Holding History

Longview Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-5,619,305
Closed -$895M – 24
2014
Q4 		$895M Sell
5,619,305
-126,003
-2% -$19.6M 6.6% 2
2014
Q3 		$807M Sell
5,745,308
-64,825
-1% -$8.46M 6.42% 2
2014
Q2 		$688M Buy
5,810,133
+304,165
+6% +$35.2M 5.44% 12
2014
Q1 		$679M Buy
+5,505,968
New +$668M 5.27% 11

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Longview Partners's AMGN Position: Q1 2015 in Review

Longview Partners sold out of Amgen (AMGN) in Q1 2015, closing a stake of 5,619,305 shares — an estimated $895M sold.

Longview Partners first reported a position in AMGN in Q1 2014 and held it in 4 quarters. The position peaked at $895M in Q4 2014. 1,344 funds tracked by Wall St. Rank hold AMGN as of Q1 2015.

  • Longview Partners reported no remaining Amgen position as of Q1 2015 after selling out during the quarter.
  • Longview Partners sold 5,619,305 Amgen shares in Q1 2015, an estimated $895M.
  • Longview Partners first reported a position in Amgen in Q1 2014 and held it in 4 quarters.
  • Longview Partners's Amgen position peaked at $895M in Q4 2014.
  • 1,344 funds tracked by Wall St. Rank held Amgen as of Q1 2015.

Based on Longview Partners's 13F filing for Q1 2015, filed 7 May 2015.